One of the richest people in Russia, oligarch Alexei Repik is responsible for the development of Mariupol and at the same time freely conducts business in the States and Germany. This was found out by the investigative project Scanner Project. It is Repik who owns the R-Stroy company, which is one of the main developers of the occupied city.
R-Stroy was founded in May 2022, at the same time Russia occupied Mariupol. The company almost immediately took up the construction of residential buildings and civil infrastructure in the city, and also participated in the "charitable projects" of the headquarters of the z-propagandist Zakhar Prilepin. The Russian authorities are actively criticizing the "collective West", and in particular the United States. At the same time, Repik himself has his own home in the United States, as well as a pharmaceutical business, the R-Pharm company. She is registered in Delaware. The company also has a factory in the German city of Illertissen. It is noteworthy that the R-Pharm and R-Stroy logos are almost identical.
Repik's $19.1 million mansion is located in San Francisco, the Scanner Project found out. The investigators also learned that at least three of the four children of the oligarch were born in the States. Repik and his family lived in the United States during the years when an armed conflict had been going on in eastern Ukraine for several years. So, in 2017, he attended the inauguration of former US President Donald Trump. At the same time, he was photographed with future CIA director Mike Pompeo and called him a "good neighbor" and "charming person."
Three months after the start of a full-scale invasion of Ukraine, Repik, fearing personal sanctions, hid himself from the list of R-Pharm owners. In August 2022, he sold the company. One of the new owners was his mother Valeria Daeva. Her company, Petrusco, is the main sponsor of R-Story. Also, the owners of the company are Konstantin Nuriev and Nikolai Milkis. The first one sells elite French wine, which Repik imports into Russia in circumvention of sanctions. The second is the CEO of Amsel Repika, which owns the eApteka service.